Company Artemis Therapeutics Inc OTC Bulletin Board
Equities
US04302Q1094
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Shimon Citron
CEO | Chief Executive Officer | 70 | 29/06/22 |
David Dana
DFI | Director of Finance/CFO | 60 | 25/07/22 |
Dana Wolf
CTO | Chief Tech/Sci/R&D Officer | 66 | 01/08/16 |
Haim Tabak
COO | Chief Operating Officer | 76 | 31/12/19 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Shimon Citron
CEO | Chief Executive Officer | 70 | 29/06/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 112,033,909 | 14,484,776 ( 12.93 %) | 0 | 12.93 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B | |
+77.64% | 8.87B |